Briggs W. Morrison M.D.
Net Worth

Last updated:

What is Briggs W. Morrison M.D. net worth?

The estimated net worth of Dr. Briggs W. Morrison M.D. is at least $27,214,916 as of 9 Aug 2023. He owns shares worth $284,484 as insider, has earned $21,579,572 from insider trading and has received compensation worth at least $5,350,860 in Syndax Pharmaceuticals, Inc..

What is the salary of Briggs W. Morrison M.D.?

Dr. Briggs W. Morrison M.D. salary is $891,810 per year as Chief Executive Officer & Director in Syndax Pharmaceuticals, Inc..

How old is Briggs W. Morrison M.D.?

Dr. Briggs W. Morrison M.D. is 65 years old, born in 1960.

What stocks does Briggs W. Morrison M.D. currently own?

As insider, Dr. Briggs W. Morrison M.D. owns shares in one company:

Company Title Shares Price per share Total value
Syndax Pharmaceuticals, Inc. (SNDX) Chief Executive Officer & Director 17,836 $15.95 $284,484

What does Syndax Pharmaceuticals, Inc. do?

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts.

SNDX logo
SNDX
Syndax Pharmaceuticals, Inc.
$15.95

Briggs W. Morrison M.D. insider trading

Syndax Pharmaceuticals, Inc.

Dr. Briggs W. Morrison M.D. has made 23 insider trades between 2019-2023, according to the Form 4 filled with the SEC. Most recently he sold 52,855 units of SNDX stock worth $965,397 on 9 Aug 2023.

The largest trade he's ever made was exercising 114,339 units of SNDX stock on 19 Sep 2022. As of 9 Aug 2023 he still owns at least 17,836 units of SNDX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 52,855 $18.27 $965,397
Option
Common Stock 52,855 $8.77 $463,538
Option
Stock Options (Right to buy) 52,855 $8.77 $463,538
Option
Stock Options (Right to buy) 52,855 $8.77 $463,538
Sale
Common Stock 52,855 $20.4 $1,078,083
Option
Common Stock 52,855 $8.77 $463,538
Option
Common Stock 28,273 $8.77 $247,954
Option
Common Stock 24,582 $6.38 $156,833
Sale
Common Stock 24,582 $21.18 $520,622
Option
Stock Options (Right to buy) 52,855 $7.58 $400,377
Sale
Common Stock 28,273 $21.18 $598,794
Option
Common Stock 52,855 $6.38 $337,215
Option
Stock Options (Right to buy) 52,855 $6.38 $337,215
Sale
Common Stock 52,855 $21.41 $1,131,467
Option
Common Stock 52,855 $6.38 $337,215
Sale
Common Stock 52,855 $19.53 $1,032,258
Option
Stock Options (Right to buy) 52,855 $6.38 $337,215
Option
Stock Option (Right to Buy) 52,854 $6.38 $337,209
Sale
Common Stock 52,854 $22.53 $1,190,695
Option
Common Stock 52,854 $6.38 $337,209
Option
Stock Options (Right to buy) 52,854 $6.38 $337,209
Sale
Common Stock 52,854 $26.83 $1,417,914
Option
Common Stock 52,854 $6.38 $337,209
Option
Stock Options (Right to buy) 59,649 $10.9 $650,174
Sale
Common Stock 59,649 $23.25 $1,387,018
Option
Common Stock 59,649 $10.9 $650,174
Sale
Common Stock 114,339 $23.03 $2,632,998
Option
Stock Options (Right to buy) 114,339 $10.9 $1,246,295
Option
Common Stock 114,339 $10.9 $1,246,295
Option
Common Stock 71,966 $7.2 $518,155
Option
Common Stock 53,034 $10.9 $578,071
Sale
Common Stock 53,034 $23.22 $1,231,449
Option
Stock Options (Right to buy) 71,966 $7.2 $518,155
Sale
Common Stock 66,775 $24.2 $1,616,022
Option
Common Stock 66,775 $7.2 $480,780
Option
Stock Options (Right to buy) 66,775 $7.2 $480,780
Sale
Common Stock 87,645 $23.8 $2,085,863
Option
Common Stock 87,645 $7.2 $631,044
Option
Stock Options (Right to buy) 87,645 $7.2 $631,044
Option
Stock Options (Right to buy) 62,292 $7.2 $448,502
Option
Common Stock 62,292 $7.2 $448,502
Sale
Common Stock 62,292 $19 $1,183,423
Sale
Common Stock 3,128 $18.29 $57,221
Option
Stock Options (Right to buy) 3,128 $7.2 $22,522
Option
Common Stock 3,128 $7.2 $22,522
Option
Common Stock 70,545 $10.9 $768,941
Sale
Common Stock 70,545 $17.46 $1,231,575
Sale
Common Stock 6,000 $17.44 $104,634
Option
Common Stock 35,156 $10.9 $383,200
Sale
Common Stock 35,156 $20 $703,120
Option
Stock Options (Right to buy) 35,156 $10.9 $383,200
Option
Common Stock 50 $7.2 $360
Option
Stock Options (Right to buy) 50 $7.2 $360
Sale
Common Stock 50 $20 $1,000
Option
Common Stock 70,262 $7.2 $505,886
Sale
Common Stock 70,262 $20.07 $1,410,018
Sale
Common Stock 35,156 N/A N/A
Option
Stock Options (Right to buy) 35,156 N/A N/A
Option
Common Stock 35,156 N/A N/A
Sale
Common Stock 17,466 N/A N/A
Option
Stock Options (Right to buy) 17,466 N/A N/A
Option
Common Stock 17,466 N/A N/A
Option
Stock Options (Right to buy) 62,938 N/A N/A
Sale
Common Stock 62,938 N/A N/A
Option
Common Stock 62,938 N/A N/A
Purchase
Common Stock 12,500 N/A N/A
Purchase
Common Stock 11,000 N/A N/A
Purchase
Common Stock 7,200 N/A N/A
Purchase
Common Stock 13,200 N/A N/A

Syndax Pharmaceuticals key executives

Syndax Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Briggs W. Morrison M.D. (65) Chief Executive Officer & Director
  • Mr. Michael A. Metzger M.B.A. (54) Pres, Chief Operating Officer & Director